Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2026 (Report No. 4)
Date of Filing: August 14, 2026
This filing reports a corporate action approved by the Board of Directors on August 11, 2026, regarding the Company's 2024 Employee Equity Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a capital structure adjustment regarding employee equity.
Material Changes
- Equity Plan Amendment: The Board approved an increase in the number of ordinary shares reserved for issuance under the 2024 Employee Equity Incentive Plan.
- Share Count Adjustment: The reserved share count increased by 2,500,000 shares, rising from 112,667 to 2,612,667 ordinary shares.
- Share Characteristics: The shares are ordinary shares with no par value per share.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document serves primarily to disclose the equity plan amendment and incorporates the report by reference into existing Registration Statements on Forms F-3 and S-8.
Investor Verification Checklist
- Verify the impact of the 2,500,000 share increase on potential dilution for existing shareholders.
- Review the terms of the 2024 Employee Equity Incentive Plan to understand vesting schedules and eligibility.
- Confirm the incorporation of this 6-K into the referenced Form F-3 and Form S-8 registration statements.